To evaluate the sample loss caused by desalting with Zip Tip, we choose one signature peptide (AGYTAIVSHR) from enolase in Thermoanaerobacter tengcongensis and another peptide (IEAIPQIDK) used for "Accuracy of the Method" as model peptides. With the peptide (AGYTAIVSHR) from enolase in Thermoanaerobacter tengcongensis, due to no ε-primary amino group in C terminal, metal labeling was directly carried out. 20 μg of the peptide was reconstituted in 20 μL of 0.2 M TEAB buffer at pH 8.0, and 60 μL of ACN and 1000 nanomoles of the DOTA-NHS ester were added, followed by incubation for 1 h at room temperature. Next, the DOTA-peptide solution was adjusted to pH 6.0 with 0.1 M NH 4 OAc and devided into two equal aliquots, and 1.2-fold molar excess of either a TbCl 3 or TmCl 3 solution to the amount of the DOTA-NHS ester was added to each aliquot, followed by incubation at 25 °C for 1 h. For evaluation by MALDI-TOF MS analysis performed on a 4800 Proteomics Analyzer (AB SCIEX, USA), each sample was first desalted with Waters Sep-Pak Vak (packed with 50 mg C18 packing materials, 78 μm, Waters Corporation, USA ) and two fractions were collected as model samples.
Examination of the sample loss when desalting with Zip Tip
To evaluate the sample loss caused by desalting with Zip Tip, we choose one signature peptide (AGYTAIVSHR) from enolase in Thermoanaerobacter tengcongensis and another peptide (IEAIPQIDK) used for "Accuracy of the Method" as model peptides. With the peptide (AGYTAIVSHR) from enolase in Thermoanaerobacter tengcongensis, due to no ε-primary amino group in C terminal, metal labeling was directly carried out. 20 μg of the peptide was reconstituted in 20 μL of 0.2 M TEAB buffer at pH 8.0, and 60 μL of ACN and 1000 nanomoles of the DOTA-NHS ester were added, followed by incubation for 1 h at room temperature. Next, the DOTA-peptide solution was adjusted to pH 6.0 with 0.1 M NH 4 OAc and devided into two equal aliquots, and 1.2-fold molar excess of either a TbCl 3 or TmCl 3 solution to the amount of the DOTA-NHS ester was added to each aliquot, followed by incubation at 25 °C for 1 h. For evaluation by MALDI-TOF MS analysis performed on a 4800 Proteomics Analyzer (AB SCIEX, USA), each sample was first desalted with Waters Sep-Pak Vak (packed with 50 mg C18 packing materials, 78 μm, Waters Corporation, USA ) and two fractions were collected as model samples.
10 μL of each Tb-labeled peptide and Tm -labeled peptide (chosen as internal standard) was pooled，and 1 μL of the mixture was analyzed on MALDI-TOF MS. As shown in Figure S1A , the ratio of peak area of Tb-labeled peptide to that of Tm -labeled peptide is 92.41 %. Then about 2 μg of Tb-labeled peptide solution was further filtered on Zip Tip and mixed with Tm -labeled peptide solution that was not filtered, this pooled solution was analyzed on MALDI-TOF MS. As shown in Figure S1B , the ratio of peak area of Tb-labeled peptide to that of Tm -labeled peptide is 87.08 %, and the recovery is 96.3 % (87.08 %/90.41 %) which suggest that little sample loss was caused when desalting with Zip Tip. In practical application, the analytes and their corresponding internal standards are prepared in same experimental conditions, therefore, about 2 μg of
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Tb-labeled peptide solution and 2 μg of Tm -labeled peptide solution were separately filtered on Zip Tip, then mixed and analyzed on MALDI-TOF MS. As shown in Figure S1C , the ratio of peak area of Tb-labeled peptide to that of Tm -labeled peptide is 92.84 %, and the recovery is 102 % (92.84 %/90.41 %) which further suggest that little sample loss was caused when desalting with Zip Tip. With another peptide (IEAIPQIDK) used for "Accuracy of the Method", due to ε-primary amino group in C terminal, 40 μg of the peptide was first modified via guanidination as described in "Labeling of Peptides" in "EXPERIMENTAL SECTION", then desalted with Waters Sep-Pak Vak, then dried and dissolved in 40 μL 0.2 mol/L pH 8.0 TEAB and finally divided into equal aliquots. The following steps are the same as those done for the peptide (AGYTAIVSHR) described above. As shown in Figure S1D , the ratio of peak area of Tb-labeled peptide to that of Tm -labeled peptide is 93.53 %, then as shown in Figure S1E , the ratio of peak area of Tb-labeled peptide to that of Tm -labeled peptide is 90.02 %, and the recovery is 96.25 % (90.02 %/93.53 %), and at last as shown in Figure S1F , the ratio of peak area of Tb-labeled peptide to that of Tm 
